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Alterations in voltage-sensing of 
the mitochondrial permeability 
transition pore in ANT1-deficient 
cells
Judit Doczi1,2, Beata Torocsik1, Andoni Echaniz-Laguna3, Bénédicte Mousson de Camaret4, 
Anatoly Starkov5, Natalia Starkova6, Aniko Gál7, Mária J Molnár7, Hibiki Kawamata5, 
Giovanni Manfredi5, Vera Adam-Vizi1 & Christos Chinopoulos1,2
The probability of mitochondrial permeability transition (mPT) pore opening is inversely related to 
the magnitude of the proton electrochemical gradient. The module conferring sensitivity of the pore 
to this gradient has not been identified. We investigated mPT’s voltage-sensing properties elicited 
by calcimycin or H2O2 in human fibroblasts exhibiting partial or complete lack of ANT1 and in C2C12 
myotubes with knocked-down ANT1 expression. mPT onset was assessed by measuring in situ 
mitochondrial volume using the ‘thinness ratio’ and the ‘cobalt-calcein’ technique. De-energization 
hastened calcimycin-induced swelling in control and partially-expressing ANT1 fibroblasts, but not 
in cells lacking ANT1, despite greater losses of mitochondrial membrane potential. Matrix Ca2+ levels 
measured by X-rhod-1 or mitochondrially-targeted ratiometric biosensor 4mtD3cpv, or ADP-ATP 
exchange rates did not differ among cell types. ANT1-null fibroblasts were also resistant to H2O2-
induced mitochondrial swelling. Permeabilized C2C12 myotubes with knocked-down ANT1 exhibited 
higher calcium uptake capacity and voltage-thresholds of mPT opening inferred from cytochrome 
c release, but intact cells showed no differences in calcimycin-induced onset of mPT, irrespective 
of energization and ANT1 expression, albeit the number of cells undergoing mPT increased less 
significantly upon chemically-induced hypoxia than control cells. We conclude that ANT1 confers 
sensitivity of the pore to the electrochemical gradient.
Mitochondria that are subject to calcium overload exhibit a permeability transition mediated by a pore forming 
in the inner mitochondrial membrane1,2. The identity of the structural components of this pore has been until 
recently unknown; in the past three years though, the c-rings of the ATP synthase3,4, and the interface within 
ATP synthase dimers5 are being strongly favoured for filling this gap of knowledge6,7,2, but still with a number 
of questions unanswered, reviewed in8–10. Nonetheless, over the past three decades extensive amount of efforts 
have focused on the regulation and functional characteristics of this phenomenon11, and an inverse correlation 
of the probability of pore opening to the magnitude of the electrochemical gradient has been thoroughly char-
acterized12–15. The molecular entity responsible for the voltage-dependence of the pore has not been identified, 
though the tuning of this sensor by the oxidation-reduction state of vicinal thiols as well as the contribution of 
critical arginines has been reported16–19. Relevant to this, glutathione depletion in cultured neurons by mon-
ochlorobimane was shown to initiate bioenergetic deficiency that was mediated by inhibition of ANT20. ANT 
exhibits a number of thiols that are amenable to oxidation by several agents21,22, some of which are unmasked in 
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an energy-dependent manner23. Strong circumstantial evidence led to the formulation of the theory that the ANT 
is a structural part of the pore24, backed by hundreds of publications showing impacts of all known ANT ligands 
on pore opening probability25.
However in 2004, the Wallace’s group showed that in the livers of genetically modified mice in which both iso-
forms of ANT were inactivated, mitochondria still exhibited Ca2+-induced pore opening albeit requiring higher 
amounts of Ca2+ loading, and that the effects of ANT ligands were completely abolished26. From this report alone, 
the ANT was deemed as modulatory but not structural component of the mPT. On the other hand, mitochondria 
obtained from the crustacean Artemia franciscana do not exhibit a calcium-regulated pore in view of profound 
calcium storage27, an organism that was recently shown to expresses a unique ANT being refractory to bong-
krekic acid28, a dual inhibitor for ANT and mPT29. Yet, ANTs expressed in related crustacean organisms that lack 
a Ca2+-induced mPT, exhibited sensitivity of ANT-mediated adenine nucleotide exchange to bongkrekic acid30, 
while allogenic expression of Artemia ANT in yeasts also conferred sensitivity to this poison31.
Mindful of the above, one may conclude that the ANT is not a structural element of the pore, however, the 
involvement of this transporter in the regulation of the mitochondrial permeability transition is more than likely. 
Hereby we investigated the response of in situ mitochondria in intact cells lacking partially or completely ANT1 
to Ca2+-induced mPT opening conferred either by i) the Ca2+-ionophore calcimycin or ii) H2O2, and as a func-
tion of the proton electrochemical gradient, also distinguishing between high- vs no electron flow in the respira-
tory chain. We also investigated the voltage thresholds of inducing mPT by submaximally loading permeabilized 
cells with calcium, and titrating mitochondrial membrane potential with cyanide or an uncoupler. Our results 
show that ANT1 is the voltage-sensor of the mPT, in line with earlier firm evidences proposing ANT as the 
voltage-sensor of the pore, as well as being the site of action of oxidative stress24,32,33.
Results
Effect of loss of ANT1gene expression on in situ mitochondrial swelling induced by calcimycin 
in human fibroblasts at different bioenergetic states. The patient (AF) exhibited a complete loss 
of ANT1 expression gene due to a homozygous G to A substitution (c.111 + 1G > A) abolishing the invariable 
consensus GT splice donor site of intron 134. The patient suffered from cardiomyopathy and myopathy, while her 
heterozygote mother (ST) was free from these clinical symptoms. In cultured fibroblasts from the patient, mito-
chondria appeared to be normal under ultrastructural examination and there were no alterations in the activities 
of respiratory chain complexes; mtDNA rearrangements or increased mtDNA copy number were absent. A thor-
ough description of the clinical case, histopathological and biochemical findings in muscle and cultured fibro-
blasts appear in ref. 34. Regarding the fibroblasts from the individuals that were used in our study, ST exhibited a 
faint band of mRNA coding for ANT1, while AF fibroblasts exhibited no band of mRNA coding for this isoform, 
in northern blotting (panel Fig. 1A,B). mRNA coding for ANT2 appeared to be unaffected (see below under 
qPCR evaluation). Western blotting analysis (panel Fig. 1C) showed that patient AF had no detectable expression 
of ANT1, while the heterozygous mother exhibited moderate ANT1 protein expression. On the contrary, ANT2 
protein expression was slightly elevated in AF cells compared to either ST cells or the three controls.
Swelling of AF, ST and three control subjects’ mitochondria within fibroblasts were compared during Ca2+ 
overload, induced by addition of calcimycin (4Br-A23187, 2 μM). Although the impact of calcium ionophores on 
in situ mitochondria has not been attributed to the permeability transition in at least one study35, there, the effect 
of the ionophore was not studied for more than 10 minutes. On the other hand, induction of the mPT in in situ 
mitochondria has been succesfully employed in many other cell models, for more extended periods of time15,36–40, 
as in the present study. The bathing solution of the cells was deprived of Mg2+ because calcimycin conducts 
Ca2+ and Mg2+ almost equally well. Understandably, mitochondrial swelling in a Ca2+-containing but Mg2+-free 
medium may be due to opening of the inner membrane anion channel “IMAC”41 and/or K+-uniport42, in addi-
tion to that attributed by the mPT; however, the first two mechanisms operate in all five cell lines, and thus would 
not serve as confounding factors in the results obtained due to differences in ANT1 expression. Mitochondria 
were visualized by wide field epifluorescence imaging of either i) mitochondrially targeted DsRed2, or ii) mito-
chondrially trapped calcein while cytoplasmic calcein fluorescence was quenched by cobalt (see below), a method 
devised by Petronilli et al.43. Swelling monitored by evaluating DsRed2-visualized mitochondrial morphology 
and changes in mean mitochondrial diameters were calculated using the thinness ratio technique, a methodol-
ogy devised by Gerencser et al.44. In these assays the onset of swelling was defined by a sudden decrease in the 
thinness ratio, δTR. A representative epifluorescence image before and after induction of mPT are shown in panel 
Fig. 1D. A time-lapse series of such experiments are shown in the Supplemental Material, as a function of met-
abolic conditions (mPT_DsRed2_control_HF_calcimycin_plus_Glc.avi, mPT_DsRed2_control_HF_calcimy-
cin_no_Glc_plus_CN.avi, and mPT_DsRed2_control_HF_calcimycin_no_Glc_plus_UNC.avi). A representative 
thinness ratio trace is shown in panel Fig. 1E, calculated from the recorded time-series images. In the experi-
ments performed with AF, ST and control subjects’ cells during various metabolic conditions described below, 
the following parameters were recorded: i) the time elapsed from the addition of calcimycin to the appearance 
of a large magnitude swelling (marked as ‘onset to mPT’, panel Fig. 1F) ii) the amplitude of swelling (marked as 
‘δTR amplitude’, panel Fig. 1G), and iii) the number of cells exhibiting the large magnitude swelling considered as 
mPT within the experimental time frame (4 hours in the presence of 2 μM calcimycin), depicted in panel Fig. 1H.
As shown in panel Fig. 1F, the calcimycin-induced swelling of in situ ST (black bars) mitochondria was has-
tened by glucose deprivation and NaCN co-application (p-value a* = 0.027, t-test); likewise, swelling of in situ 
mitochondria of two out of the three control subjects’ cells (white bars) was hastened by glucose deprivation 
and NaCN co-application (p-value: b* = 0.005, t-test and c* = 0.04, t-test). This is consistent with the findings 
on mouse mitochondria reported previously by our group15, and in line with the established phenomenon that 
a diminished electrochemical gradient primes mitochondria to undergo Ca2+-induced mPT. However, the 
calcimycin-induced swelling of in situ AF (grey bars) mitochondria was delayed, compared to other cell types 
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Figure 1. Effect of loss of ANT1 gene expression on in situ mitochondrial swelling (visualized by 
DsRed2) induced by calcimycin in human fibroblasts during various metabolic conditions [+ glucose, 
no glucose + 2-deoxyglucose (2 mM) + NaCN (5 mM), no glucose + 2-deoxyglucose + SF 6847 (SF, 1 μM), 
detailed in the y-axis of the panels]. (A) Northern blot image of ST cells for ANT1 and ANT transcripts.  
(B) Northern blot image of AF cells for ANT1 and ANT2 transcripts. (C) Scanned images of Western blots 
of AF, ST and control cells from three healthy donors (35 μg loading per lane) directed against ANT1, ANT2, 
VDAC1 and β-actin. (D) Epifluorescence image of a fibroblast transfected with DsRed2 before and after 
induction of mPT. (E) Representative trace of the effect of calcimycin (2 μM) on the thinness ratio (δTR) 
indicating mitochondrial volume as a function of time. (F) Time elapsed between calcimycin application and 
mitochondrial swelling (onset to mPT) detected by wide field imaging of mito-DsRed2 expressed in cultured 
fibroblasts from the heterozygous mother (ST, black bars) the patient (AF, grey bars), and three control subjects 
(white bars) during various metabolic conditions, detailed under the x-axis. The onset to mPT was determined 
by the sudden increase of mean mitochondrial diameter in the microscopic view field described as a sudden 
decrease of the thinness ratio (δTR). Bars indicate means ± S.E.M. of 14–43 cells from at least 8 different cultures as 
detailed in panel 1D (*p < 0.05 significance by Student’s t-test for ‘a’ ‘b’ and ‘c’ or ANOVA ‘d’; p-values: *a = 0.027, 
*b = 0.005, *c = 0.04, *d = 0.027. (G) Quantification of the δTR amplitude (as marked in panel F) for AF vs ST vs 
control cells during various metabolic conditions, detailed on the x-axis. (H) Comparison of mPT-exhibiting and 
non-exhibiting cells (bricks) in fibroblasts from ST (black bars), AF (grey bars) and control subjects (white bars) 
with the TR technique during various metabolic conditions, detailed on the x-axis, using Fisher exact test.
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during glucose deprivation and NaCN co-application (p-value: d* = 0.027, one-way ANOVA); furthermore, 
this parameter was not statistically significantly different from the other cell types during energized conditions. 
Although the above tendencies were the same for ST and AF cells during glucose deprivation and co-application 
of the uncoupler SF 6847 compared to the fully energized state, no statistically significant difference was reached.
Within the 4 hours of the experimental time frame the amplitude of swelling (panel Fig. 1G) was not sig-
nificantly different between ST, AF or control cells under any metabolic condition. This is important, because 
different cell types exhibit different amplitudes of swelling, for unknown reasons44. The absence of a difference in 
these amplitudes among AF, ST and control cell mitochondria imply that the absence of ANT1 in AF cells did not 
confer a large, confounding alteration, thus supporting the notion that the mechanism of swelling must be the 
same for all cells, likely the opening of the permeability transition pore. Accordingly, as shown in panel Fig. 1H, 
the number of cells exhibiting large-magnitude swelling within the 4 hours of the experimental time frame was 
also not statistically significant among any cell type.
Visualization of DsRed2-expressing mitochondria offers superior imaging quality and the fluorescent pro-
tein does not exit mitochondria upon swelling. However, transfection efficiency is very low, typically less than 
5% in fibroblasts. Therefore, we complemented this approach with the cobalt-calcein technique, a method that 
outlines the mitochondrial network of all cells. On the other hand, the amount of calcein loading has to be 
carefully titrated, as it may be toxic to the cells, plus mitochondrially-trapped calcein fluorescence is lost rapidly 
after opening of the mPT. In our hands, 50 nM of calcein-AM loading at 4 °C was optimal; below this concen-
tration the signal-to-noise ratio was unsatisfactory, while above 100 nM mitochondria from all cell types frag-
mented a few minutes after loading. Representative epifluorescence images of cells before and after induction 
of mPT are shown in panel Fig. 2A,B, respectively. A time-lapse series of such an experiment is shown in the 
Supplemental Material (mPT_COBCA_control_HF_calcimycin_plus_Glc.avi). The thinness ratio technique 
cannot be applied on calcein-loaded mitochondria, so therefore organellar volume cannot be quantified; using 
the cobalt-calcein method we only investigated the time elapsing from addition of calcimycin to transforma-
tion of mitochondria from a thread-to-ball configuration followed by immediate loss of calcein fluorescence, 
implying mPT opening. Furthermore, we only investigated the effect of glucose (fully energized state) versus 
no glucose plus 2-deoxyglucose plus NaCN (fully de-energized state, no electron flow), because the uncoupler 
SF 6847 was rapidly quenching mitochondrially-trapped calcein fluorescence. The time elapsed until onset of 
mPT assessed by the cobalt-calcein technique (cob-calc) was less than that assessed by the thinness ratio tech-
nique (compare panel Fig. 1F with 2C), in the energized state; this likely reflects the toxicity of loading with 
calcein. Nevertheless, as shown in panel Fig. 2C, the calcimycin-induced swelling of in situ AF (grey bars) 
mitochondria was delayed, compared to other cell types during glucose deprivation and NaCN co-application 
(p-value: e* = 0.002, one-way ANOVA). The time elapsed until mPT onset of in situ AF (grey bars) mitochon-
dria was also significantly increased in the de-energized compared to the energized state (p-value: f* = 0.008, 
t-test). The same tendency was observed in the experiments with DsRed2-transfected cells. Similar to the results 
obtained from DsRed2-expressing mitochondria, as shown in panel Fig. 2D, the number of cells exhibiting loss of 
mitochondrially-entrapped calcein fluorescence within the experimental time frame was also not statistically sig-
nificant among any cell type. From the above data we concluded that the absence of ANT1 increased the elapsed 
time to mPT opening upon calcimycin addition only during the de-energized state.
Effect of complete loss of ANT1 gene expression on matrix Ca2+ accumulation upon treatment 
with calcimycin. To show that application of calcimycin to cells leads to matrix Ca2+ accumulation irre-
spective of the de-energization treatment and to address the possibility that the alterations seen in the elapsed 
time to mPT upon calcimycin addition between the cell lines (results obtained from the control cell lines were 
pooled) could be affected by alterations in the accumulation of Ca2+ in the mitochondrial matrix, we evaluated 
matrix Ca2+ levels by i) mitochondrially trapped X-rhod-1 (Kd for Ca2+ = 0.7 μM) and ii) genetically encoded, 
mitochondrially-targeted, ratiometric calcium biosensor that contains enhanced CFP and circularly permuted 
Venus 173, 4mtD3cpv45, (Kd for Ca2+ = 0.6 μM). This FRET-based ratiometric indicator exhibits a nearly exclu-
sive preference for the mitochondrial compartment compared to X-rhod-1 distribution (not shown), though this 
methodology suffers from low transfection efficiency (typically less than 5%). On the other hand, with X-rhod-1 
we could evaluate more cells, but the fluorescence signal could also be partially originating from the cytosolic 
compartment.
Mitochondrial matrix Ca2+ accumulation was induced in the various fibroblasts lines in the same manner 
as for the ‘thinness ratio’, while cells were either loaded with X-rhod-1 (panel Fig. 3A,C,E) or transfected with 
pcDNA-4mtD3cpv (panel Fig. 3B,D,F). As seen in panel Fig. 3A, representative traces (grey) of X-rhod-1 flu-
orescence signal representing matrix Ca2+ of in situ mitochondria are shown from a typical experiment; upon 
addition of calcimycin (2 μM), there is a gradual elevation in X-rhod-1 fluorescence that reaches a plateau within 
30 minutes. The mean trace with S.E.M. bars is shown superimposed in black. In panel Fig. 3B, a representa-
tive trace of 4mtD3cpv FRET ratio fluorescence is shown, in response to addition of calcimycin. From such 
experiments we evaluated matrix Ca2+ levels in the various cell lines during the exact metabolic conditions as 
indicated for panel Fig. 1F, with the following two parameters: i) the rate of change in X-rhod-1 and 4mtD3cpv 
FRET ratio fluorescence within the first 10 minutes upon addition of calcimycin, and ii) the plateau of X-rhod-1 
and 4mtD3cpv FRET ratio fluorescence reached within one hour upon addition of calcimycin. The results of the 
first parameter are shown in panel Fig. 3C,D and for the second parameter in panel Fig. 3E,F for X-rhod-1 and 
4mtD3cpv FRET ratio fluorescence, respectively. All of the results shown in Fig. 3 imply that there is a substan-
tial elevation in matrix Ca2+ concentration induced by calcimycin even in the presence of cyanide or uncoupler. 
However, there was a statistically significant decrease in matrix Ca2+ accumulation recorded by 4mtD3cpv FRET 
ratio fluorescence (panel Fig. 3D) in AF cells compared to ST (p = 0.044) and control fibroblasts (p = 0.042) 
during de-energization by cyanide. No statistically significant difference was recorded for any other comparison.
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Figure 2. Effect of loss of ANT1 gene expression on in situ mitochondrial swelling (visualized by the cobalt-
calcein technique) induced by calcimycin in human fibroblasts during various metabolic conditions [+ glucose, 
no glucose + 2-deoxyglucose (2 mM) + NaCN (5 mM), detailed in the y-axis of the panels]. (A) Epifluorescence 
image of calcein-loaded fibroblasts before induction of mPT. (B) Epifluorescence image of the same fibroblasts as 
shown in panel A, after induction of mPT. (C) Time elapsed between calcimycin application and mitochondrial 
swelling (onset to mPT) detected by wide field imaging of calcein-loaded cultured fibroblasts from the heterozygous 
mother (ST, black bars) the patient (AF, grey bars), and three control subjects (white bars) during various metabolic 
conditions, detailed under the x-axis, in the presence of CoCl2. Bars indicate means ± S.E.M. of 29–53 cells from 
at least 8 different cultures (*p < 0.05 significance by ANOVA; p: *e = 0.002, *f = 0.008; cob-calc: cobalt-calcein 
technique. (D) Comparison of mPT-exhibiting and non-exhibiting cells (bricks) in fibroblasts from ST (black bars), 
AF (grey bars) and control subjects (white bars) with the cobalt-calcein technique, using Fisher exact test.
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Figure 3. Effect of loss of ANT1 gene expression on matrix Ca2+ accumulation upon treatment with 
calcimycin. (A) Representative traces (grey lines) and superimposed mean (black line with S.E.M.) of the effect 
of calcimycin (2 μM) on mitochondrially-trapped X-Rhod-1 fluorescence, reflecting matrix Ca2+ levels.  
(B) Representative trace of the effect of calcimycin (2 μM) on mitochondrially-targeted FRET-based 4mtD3cpv 
ratio fluorescence, reflecting matrix Ca2+ levels. (C) Quantification of changes in X-rhod-1 fluorescence within 
the first 10 min upon addition of calcimycin for various metabolic conditions indicated under the x-axis in 
cultured fibroblasts from the heterozygous mother (ST, black bars) the patient (AF, grey bars), and three control 
subjects (pooled cells shown in white hatched bars) during various metabolic conditions, detailed under 
the x-axis. Bars indicate means ± S.E.M. of 25–40 cells from at least 5 different cultures. (D) Quantification 
of changes in 4mtD3cpv ratio fluorescence within the first 10 min upon addition of calcimycin for various 
metabolic conditions indicated under the x-axis in cultured fibroblasts from the heterozygous mother (ST, 
black bars) the patient (AF, grey bars), and three control subjects (pooled cells shown in white hatched bars) 
during various metabolic conditions, detailed under the x-axis. Bars indicate means ± S.E.M. of 6–10 cells 
from at least 4 different cultures; p-values: *a = 0.042, *b = 0.044. (E) Quantification of maximal changes in 
X-rhod-1 fluorescence upon addition of calcimycin for various metabolic conditions indicated under the x-axis 
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Effect of complete loss of ANT1 gene expression on in situ ΔΨm upon treatment with calcimycin. 
As stated above, the threshold of mPT opening depends on the extent of ΔΨm; de-energization by cyanide in 
the abscence of glucose would lead to reversal of the mitochondrial ATP synthase in an attempt to maintain 
membrane potential, at the expense of hydrolysing ATP originating from either cytosol (glycolysis) or mito-
chondrial substrate-level phosphorylation46–50. Thus, during the de-energization protocol and in the presence of 
calcimycin, a complete collapse of ΔΨm in our cell lines is not warranted and the presence of a residual potential 
value is more than likely. To address the status of ΔΨm of the various fibroblast cell lines we measured mito-
chondrial membrane potential by TMRM and distinguishing it from a plasma membrane distribution signal by 
co-loading with DiBAC4(3), a negatively charged potentiometric dye. Our method is a variant of that described 
by Gerencser and colleagues51 which used PMPI instead of DiBAC4(3). We used DiBAC4(3) because it exhibits 
less spectral overlap with TMRM. Representative epifluorescence images of TMRM and DiBAC4(3) fluorescence 
representing ΔΨm and plasma membrane potential (ΔΨp) respectively, are shown in Supplemental Fig. 1 during 
addition of the calibrants (see below); image processing flow of the spectral un-mixing performed as described 
in52 is depicted in Supplemental Fig. 2, resulting in the images shown in Fig. 4A. Specifically, the calibration of 
plasma membrane potential was performed by establishing a K+-equilibrium potential (K+ equil) at the plasma 
membrane followed by stepwise increments of extracellular [K+] (exact values indicated in panel Fig. 4B,C and 
Supplemental Fig. 1). The K+-equilibrium potential was established by the application of 10 μM diazoxide. Finally, 
a cell membrane calibration cocktail (CDC) was applied. TMRM signals originating from the mitochondrial 
compartment was then recorded by spectrally un-mixing the DiBAC4(3) fluorescence signal as described in51 
using decomposition algorithms developed in52.
Representative traces (grey lines) of TMRM fluorescence (spectrally un-mixed from DiBAC4(3) fluorescence, 
see Supplemental Figs 1 and 2 and details under Materials and Methods) reflecting mitochondrial membrane 
potential from control fibroblasts under energized conditions are shown in panel Fig. 4D; the mean trace with 
S.E.M. bars is shown superimposed in black. As shown in panel Fig. 4D, addition of calcimycin decreased TMRM 
fluorescence by approximately 40%; residual ΔΨm was lost upon further addition of a mitochondrial membrane 
depolarization cocktail (MDC), the composition of which is detailed under Materials and Methods. From such 
experiments we evaluated ΔΨm levels in the various cell lines (results obtained from the control cell lines were 
pooled) during the exact metabolic conditions as indicated for panel Fig. 1F, by taking into account the ratio of 
calcimycin-induced (ΔFcalcimycin) to MDC-induced (ΔFtotal) change in TMRM fluorescence. The results are sum-
marized in panel Fig. 4E; as shown in panel Fig. 4E, the mitochondrial de-energization induced by calcimycin -in 
addition to that by cyanide- is highly significantly (p = 0.001) greater in AF cells compared to either ST or control 
cells. Yet, the time lag until onset to mPT (shown in panel Fig. 1F) is greater under the same de-energization 
conditions for the AF cells. These two results are strongly supportive of the notion that lack of ANT1 renders 
mitochondria insensitive to modulation of mPT opening by the mitochondrial membrane potential. On the other 
hand, ΔΨp inferred by DiBAC4(3) fluorescence remained relatively unchanged (<2% changes), panel Fig. 4F. 
The fact that plasma membrane potential does not show large fluctuations, affords greater assurance that the 
TMRM signals are almost entirely due to fluctuations of the mitochondrial membrane potential, since TMRM is 
known to distribute across the plasma membrane as well53.
Effect of loss of ANT1 gene expression on in situ mitochondrial swelling induced by H2O2 in 
human fibroblasts. To address the role of ANT1 on mPT induced by a different than Ca2+-overload stim-
ulus, we subjected the fibroblasts to an oxidant treatment by 1 mM H2O2. Reactive oxygen species are known 
to induce mPT54. Just like with calcimycin, treatment of DsRed2-transfected cells with H2O2 (without omitting 
Mg2+ from the medium) led to an abrupt change in mitochondrial morphology which by the thinness ratio 
technique is quantified as swelling, thus implying mPT opening. Representative epifluorescence images of a cell 
before and after mPT induction are shown in panel Fig. 5A,B, respectively. A time-lapse series of such an exper-
iment is shown in the Supplemental Material (mPT_DsRed2_control_HF_H2O2.avi). A representative thinness 
ratio trace is shown in panel Fig. 5C, calculated from the recorded time-series images. In the experiments using 
H2O2 as an mPT inducer, we did not variate the metabolic conditions by omitting glucose or including cyanide 
or uncoupler, because H2O2 is expected to exert a considerable metabolic challenge itself55. In AF, ST and pooled 
control subjects’ cells, the following parameters were recorded: i) the time elapsed from the addition of H2O2 to 
the appearance of a large magnitude swelling (marked as ‘onset to mPT’, panel Fig. 5D), and ii) the number of cells 
exhibiting the large magnitude swelling considered as mPT within the experimental time frame (4 hours in the 
presence of 1 mM H2O2), depicted in panel Fig. 5E.
As shown in panel Fig. 5D, the H2O2-induced onset to mPT of in situ ST (black bar) mitochondria was sim-
ilar to that from the control cells (cross-hatched white bar). However, the H2O2-induced onset to mPT of in situ 
AF (grey bar) mitochondria was delayed, compared to other cell types. Although this difference is large (~60% 
further delay in onset to mPT), it was not statistically significantly different from the other cell types but that is 
in cultured fibroblasts from the heterozygous mother (ST, black bars) the patient (AF, grey bars), and three 
control subjects (pooled cells shown in white hatched bars) during various metabolic conditions, detailed under 
the x-axis. Bars indicate means ± S.E.M. of 25–40 cells from at least 5 different cultures. (F) Quantification of 
maximal changes in 4mtD3cpv ratio fluorescence upon addition of calcimycin for various metabolic conditions 
indicated under the x-axis in cultured fibroblasts from the heterozygous mother (ST, black bars) the patient 
(AF, grey bars), and three control subjects (pooled cells shown in white hatched bars) during various metabolic 
conditions, detailed under the x-axis. Bars indicate means ± S.E.M. of 6–10 cells from at least 4 different 
cultures.
www.nature.com/scientificreports/
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Figure 4. Effect of loss of ANT1 gene expression on in situ ΔΨm upon treatment with calcimycin.  
(A) Spectrally un-mixed epifluorescence images of TMRM and DIBAC4(3) fluorescence representing  
ΔΨm and ΔΨp respectively; the methodology of spectral un-mixing is outlined in Supplemental Figs 1 and 2.  
(B) DIBAC4(3) fluorescence traces (grey traces) after spectral un-mixing from TMRM fluorescence bleed-
through. DIBAC4(3) fluorescence intensities (black scatters), indicating mean ± SEM of fluorescence measured 
over n = 20 fibroblasts (grey lines) in a representative experiment. (C) TMRM fluorescence traces after spectral un-
mixing from DIBAC4(3) fluorescence bleed-through (corresponding DIBAC4(3) fluorescence shown in panel B).  
TMRM fluorescence intensities (black scatters), indicating mean ± SEM of fluorescence measured over n = 20 
fibroblasts (grey lines) from the same experiment, shown in panel B. (D) Representative traces (grey lines) and 
superimposed mean (black line with S.E.M.) of the effect of calcimycin (2 μM) on TMRM fluorescence, spectrally 
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only because a very low number of cells (only three) underwent mPT, reducing the power of statistical analysis. 
Exactly because of this reason, as shown in panel Fig. 5E, the number of AF cells that underwent mPT was much 
smaller (p = 0.0058) that the other cell types, also leading to not significant differences between AF and control 
cells evaluated with the Fisher exact test (p = 0.06), but yielded significance using the less stringent Chi-square 
test (p = 0.029).
From the above data we concluded that the absence of ANT1 may increase the elapsed time to mPT upon 
H2O2 addition, but most importantly prevent cells from undergoing mPT. These results are in accordance to those 
by Kokoszka and colleagues26, where they showed that although tert-butyl hydroperoxide, a non-specific oxidant, 
and diamide, a specific –SH group oxidant, facilitated isolated mouse liver mitochondria to undergo mPT inde-
pendent of the presence of ANT, ANT1−/− /ANT2−/− deficient mice exhibited more than three times higher 
maximum Ca2+ uptake capacity compared to wild-type mice26.
Effect of knocking-down Ant1 expression in C2C12 myotubes on in situ mitochondrial swelling 
induced by calcimycin at different bioenergetic states. In order to evaluate the role of ANT1 on 
voltage-sensing properties of the mPT in a different cell context, we knocked-down its gene by stably expressing 
lentiviral shRNA targeted against mouse Ant1 as performed in56, and swelling of in situ mitochondria of these 
versus scramble RNA (scr) transfected cells were compared during Ca2+ overload induced by addition of calci-
mycin, as a function of various metabolic conditions. As in Kawamata et al.56, ANT1 expression in shRNA-treated 
cells was undetectable by Western blotting (see panel Fig. 6A), and qPCR for mRNA was reduced by over 90% 
(not shown). Expression of ANT2 was unaffected, (panel Fig. 6A). In situ mitochondria were visualized by 
wide field epifluorescence imaging of mitochondrially targeted DsRed2. Swelling was monitored by evaluating 
DsRed2-visualized mitochondrial morphology and changes in mean mitochondrial diameters were calculated 
using the thinness ratio technique. Representative epifluorescence images before and after induction of mPT 
are shown in panel Fig. 6B. Time-lapse series of such experiments from an shRNA-transfected and a scramble 
RNA-transfected C2C12 cell are shown in the Supplemental Material, (mPT_DsRed2_C2C12_shRNA_ANT1.avi, 
and mPT_DsRed2_C2C12_scramble_ANT1.avi). A representative thinness ratio trace is shown in panel Fig. 6C, 
calculated from the recorded time-series images. In the experiments performed with shRNA ANT1-transfected 
and a scramble RNA-transfected C2C12 cells during various metabolic conditions as described in the legend 
and panels, the following parameters were recorded: i) the time elapsed from the addition of calcimycin to the 
appearance of a large magnitude swelling (marked as ‘onset to mPT’, panel Fig. 6D) and ii) the number of cells 
exhibiting the large magnitude swelling considered as mPT within the experimental time frame (4 hours in the 
presence of 2 μM calcimycin), depicted in panel Fig. 6E. As shown in panel Fig. 6D, the calcimycin-induced 
onset to mPT in C2C12 cells with knocked-down ANT1 did not exhibit a statistically significant difference from 
scramble RNA transfected cells, under any metabolic conditions. However, as shown in panel Fig. 6E, the number 
of cells exhibiting large-magnitude swelling within the 4 hours of the experimental time frame was statistically 
significantly different among these cell types when comparing glucose deprivation and NaCN co-application ver-
sus no glucose deprivation. Nonetheless, the number of C2C12 cells with knocked-down Ant1 undergoing mPT 
increased less significantly (p = 0.0089 vs p = 0.0237) upon chemically-induced hypoxia than cells transfected 
with scramble RNA. This observation attests to the notion that ANT1 at least partially regulates mPT opening 
as a function of energization level of in situ mitochondria. However, in this experimental setting and just like in 
human fibroblasts, de-energization by uncoupler did not confer the same alterations in mPT exhibiting versus 
non-exhibiting cells.
Effect of knocking-down Ant1 expression in permeabilized C2C12 myotubes on the voltage 
threshold of calcium-induced mPT. We further evaluated the role of ANT1 on the voltage threshold of 
calcium-induced mPT under various metabolic conditions, in permeabilized C2C12 cells and measuring mito-
chondrial calcium uptake, ΔΨm, and cytochrome c release using the following protocols: i) maximum calcium 
uptake of in situ mitochondria supported by glutamate and malate (panels 7A and 7B, recording calcium uptake 
and ΔΨm, respectively), ii) challenge by submaximal CaCl2 dose followed by titration with step-wise inhibition 
of respiration by NaCN (50 μM boluses) shown in panels 7C and 7D, recording calcium uptake and ΔΨm, respec-
tively, iii) challenge by submaximal CaCl2 dose followed by titration with step-wise dissipation of ΔΨm by SF6847 
(10 nM boluses) shown in panels 7E and 7F, recording calcium uptake and ΔΨm, respectively, and iv) measuring 
cytochrome c released from the in situ mitochondria of the permeabilized cells during the following time points, 
indicated in panels 7C and 7E: 1 = before calcium additions, 2 = right after calcium additions, 3 = before loss of 
sequestered calcium and membrane potential, 4 = after loss of sequestered calcium in scramble RNA treated cells 
but not shRNA treated cells, 5 = after loss of sequestered calcium and membrane potential in both cells types, 
un-mixed from DIBAC4(3) fluorescence, reflecting ΔΨm. (E) Quantification of changes in TMRM fluorescence, 
spectrally un-mixed from DIBAC4(3) fluorescence for the various metabolic conditions indicated under the 
x-axis, for cultured fibroblasts from the heterozygous mother (ST, black bars) the patient (AF, grey bars), and three 
control subjects (pooled cells shown in white cross-hatched bars). Bars indicate means ± S.E.M. of 168–227 cells 
from at least 5 different cultures; p-values: *a < 0.001, *b < 0.001. (F) Quantification of changes in DIBAC4(3) 
fluorescence for the various metabolic conditions indicated under the x-axis, for cultured fibroblasts from the 
heterozygous mother (ST, black bars) the patient (AF, grey bars), and three control subjects (pooled cells shown in 
white cross-hatched bars). Bars indicate means ± S.E.M. of 168–227 cells from at least 5 different cultures.
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Figure 5. Effect of loss of ANT1 gene expression on in situ mitochondrial swelling (visualized by DsRed2) 
induced by H2O2 in human fibroblasts. (A) Epifluorescence image of a fibroblast transfected with DsRed2 
before induction of mPT. (B) Epifluorescence image of the same fibroblast as shown in panel 5A, after induction 
of mPT by H2O2. (C) Representative trace of the effect of H2O2 (1 mM) on the thinness ratio (δTR) indicating 
mitochondrial volume as a function of time. (D) Time elapsed between H2O2 application and mitochondrial 
swelling (onset to mPT) detected by wide field imaging of mito-DsRed2 expressed in cultured fibroblasts from 
the heterozygous mother (ST, black bars) the patient (AF, grey bars), and three control subjects (white cross-
hatched bars) in the presence of glucose. The onset to mPT was determined by the sudden increase of mean 
mitochondrial diameter in the microscopic view field described as a sudden decrease of the thinness ratio  
(δTR). Bars indicate means ± S.E.M. of 18–24 cells from at least five different cultures. (E) Comparison of 
mPT-exhibiting and non-exhibiting cells (bricks) in fibroblasts from ST (black bars), AF (grey bars) and control 
subjects (white bars) with the TR technique, using Fisher exact test.
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plus a time control for point 5 (cells were probed for cytochrome c release after 20 min of incubation but were 
not challenged by either CaCl2 or NaCN or uncoupler) and an alamethicin (a pore-forming peptide) control. 
The amount of cytochrome c appearing in the supernatant upon treatment with alamethicin provides a meas-
ure of the maximum amount releasable57. Calcium uptake and ΔΨm measurements were performed in parallel 
but different samples (but from the same cultures) due to spectral overlap of calcium green and safranine O. 
The assessment of maximum calcium uptake capacity is a widely utilized protocol58,59, that can be performed in 
Figure 6. Effect of knocking-down Ant1 in C2C12 myotubes by shRNA using lentiviruses, versus scramble 
RNA-transfected cells on calcimycin-induced mitochondrial swelling or maximum calcium uptake capacity. 
(A) Scanned images of Western blots of C2C12 myotubes (10 μg loading per lane) transfected with shRNA 
directed against Ant1 or scramble (scr) RNA, for ANT1, ANT2, VDAC1 and β-actin. (B) Epifluorescence image 
of a C2C12 myotube transfected with DsRed2 before and after induction of mPT. (C) Representative trace of the 
effect of calcimycin (2 μM) on the thinness ratio (δTR) indicating mitochondrial volume as a function of time.  
(D) Time elapsed between calcimycin application and mitochondrial swelling (onset to mPT) detected by wide 
field imaging of mito-DsRed2 expressed in cultured C2C12 cells treated with shRNA for Ant1 or scramble RNA 
during various metabolic conditions, detailed under the x-axis. The onset to mPT was determined by the sudden 
increase of mean mitochondrial diameter in the microscopic view field described as a sudden decrease of the 
thinness ratio (δTR). Bars indicate means ± S.E.M. of 18–21 cells from at least five different cultures.  
(E) Comparison of mPT-exhibiting and non-exhibiting cells (bricks) detected with the TR technique during 
various metabolic conditions, using Fisher exact test.
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Figure 7. Determination of voltage thresholds of calcium-induced mPT in permeabilized C2C12 cells 
treated with shRNA for Ant1 (red inverted triangles) or scramble RNA (black closed circles), under 
various metabolic conditions. (A) Maximum calcium uptake capacity in permeabilized C2C12 cells treated 
with shRNA for Ant1 or scramble RNA. Each addition of CaCl2 (Ca) is 100 μM. (B) Safranine O fluorescence 
traces of C2C12 cells treated exactly as in panel A. Mitochondrial substrates were 5 mM glutamate and 5 mM 
malate. (C) Cells were challenged by two additions of CaCl2 (Ca, 100 μM each) followed by consecutive 
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isolated60, or in situ mitochondria of permeabilized cells. In our hands, permeabilized human fibroblasts exhib-
ited a very small maximum mitochondrial calcium uptake capacity, less than 10 nmol/mg protein, and therefore, 
experiments with these cells were not conducted. On the contrary, permeabilized C2C12 myotubes exhibited very 
large maximum calcium uptake capacities, providing the opportunity for a more thorough investigation of mPT 
opening by calcium loading as a function of various metabolic conditions. We have tried to isolate mitochondria 
from fibroblasts and C2C12 cells, but there were insurmountable obstacles with both cell types; with fibroblasts, 
an extremely small amount of isolated mitochondria was obtained, not suitable for functional experiments; with 
C2C12 cells only very harsh homogenization methods could yield sufficient amount of mitochondria, but they 
were damaged to the extent that they were too leaky for functional studies. For these reasons, we only evaluated 
C2C12 cells. shRNA-transfected and scramble RNA-transfected C2C12 cells were permeabilized as described 
under ‘Materials and Methods’, boluses of 100 μM CaCl2 (panel Fig. 7A,B) were added where indicated, and 
extramitochondrial Ca2+ levels were followed by Calcium Green 5N hexapotassium salt fluorescence (Fig. 7A), 
or ΔΨm, using safranine O (Fig. 7B). As shown in panel Fig. 7A, C2C12 cells with knocked-down Ant1 exhib-
ited larger mitochondrial calcium uptake capacity than scramble-transfected cells, in the presence of glutamate 
(5 mM) and malate (5 mM). It is to be noted, that this is not a condition in which mitochondria are continuously 
fully energized; it is well understood that upon progressive mitochondrial calcium sequestration, mitochondria 
depolarize accordingly61. Indeed, as shown in figure panel 7B, ΔΨm of both cell types gradually dissipates upon 
increasing calcium load. However, as it is marked by black dashed line for scr RNA-treated cells and red dashed 
line for shRNA-treated cells, those cells with knocked-down ANT1 expression exhibited loss of sequestered cal-
cium in a much more depolarized ΔΨm range, nearing that of complete depolarization. Next, to obtain a more 
accurate indication of how mPT opening relates to ΔΨm, we challenged in situ mitochondria of permeabilized 
C2C12 cells with an amount of CaCl2 that is insufficient to trigger pore opening, and then dissipated ΔΨm grad-
ually by inhibiting complex IV with cyanide (50 μM boluses, Fig. 7C,D) or using the uncoupler SF 6847 (10 nM 
boluses Fig. 7E,F), while recording extramitochondrial Ca2+ levels (Fig. 7C,E), or ΔΨm (Fig. 7D,F). In figure 
panel 7D the addition of 100 nM SF 6847 is also shown (red arrow), signifying that just prior to its addition there 
was a considerable extent of ΔΨm that could be dissipated. As shown in Fig. 7C–F and marked by black dashed 
line for scr RNA-treated cells and red dashed line for shRNA-treated cells, those cells with knocked-down ANT1 
expression exhibited loss of sequestered calcium in a much more depolarized ΔΨm range, again nearing that of 
complete depolarization. Furthermore, as shown in figure panels 7G and 7H, a higher percentage of cytochrome c 
was released from scr RNA treated cells at time points 4 and 5 compared to that from shRNA treated cells, imply-
ing that the loss of ΔΨm and sequestered calcium during the same time frame is due to large amplitude swelling 
resulting in rupture of the outer mitochondrial membrane, implying mPT opening. From these experiments we 
concluded that ANT1 regulates the voltage threshold of calcium-induced mPT opening.
Effect of complete loss of ANT1 gene expression on ADP-ATP exchange rates as a function of 
ΔΨm. Human fibroblasts express three (1, 2 and 3) out of the four known isoforms of ANT. ANT2 was not 
evaluated particularly for AF and ST cells in ref. 34, therefore we quantified this transcript by qPCR. As shown in 
panel Fig. 8A, AF cells did not exhibit a statistically significant increase of the ANT2 gene expression compared 
to ST and control subject cells. This and the unchanged levels of ANT3 expression reported in ref. 34 yielded 
ADP-ATP exchange rates as a function of ΔΨm that did not differ between AF, ST and control subjects’ cells, 
shown in panel Fig. 8B. As reported in ref. 34, AF cells did not express ANT1 (verified in results shown in panel 
Fig. 1B,C). From these results we concluded that the differences in onset of the calcimycin-induced mPT between 
AF, ST and control subjects’ cells were unlikely to be attributed to alterations in the adenine nucleotide and/or 
ΔΨm levels. The determination of the amount of functional ANTs by means of titration with carboxyatractylo-
side while measuring respiration could not be reliably performed due to the low amount of mitochondria that 
could be accessed in the permeabilized cultures; this is because the amount of carboxyatractyloside required, was 
estimated to be in the low nanomolar range, i.e. near the Ki of the inhibitor for the ANT (not shown). Neither 
AF nor ST cells exhibited appreciable ANT reversal rates, probably due to the prominent expression of IF-1 in 
human fibroblasts62, also supported by our findings with the cells from three different control subjects, shown in 
panel figure bB.
additions of 50 μM NaCN, and extramitochondrial calcium was measured by CaGr. Blue numbers and arrows 
signify time-points of probing for cytochrome c release (see panel G). (D) Safranine O fluorescence traces 
of C2C12 cells treated exactly as in panel C, with the exception that shRNA-treated cells received a bolus of 
100 nM SF6847 as shown by the red arrow, to indicate that prior to this addition a significant portion of ΔΨm 
remained. (E) Cells were challenged by two additions of CaCl2 (Ca, 100 μM each) followed by consecutive 
additions of 10 nM SF6847, and extramitochondrial calcium was measured by CaGr. Blue numbers and 
arrows signify time-points of probing for cytochrome c release (see panel H). (F) Safranine O fluorescence 
traces of C2C12 cells treated exactly as in panel E. All traces shown in panels (A-F) are representative 
of 5 independent experiments. (G) Cytochrome c release (% of the total) estimated by enzyme-linked 
immunosorbent assay from permeabilized C2C12 cells probed at time points (1–5) indicated in panel C; 
*a = 0.034, *b = 0.049. (H) Cytochrome c release (% of the total) estimated by enzyme-linked immunosorbent 
assay from permeabilized C2C12 cells probed at time points (1–5) indicated in panel E; *c = 0.047, *d = 0.041. 
‘Time-controls (t.c.)’ signify probing of C2C12 cells at time-point 5 for cytochrome c release that have not 
been treated with either CaCl2 or NaCN nor SF6847. ‘Alm’ signifies probing of C2C12 cells for cytochrome c 
release that have been treated with 80 ngr of alamethicin. Bars indicate means ± S.E.M. of ~270,000 cells from 
3 different cultures.
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Discussion
mPT is implicated in many human diseases2,63. Extensive characterization of the phenomenon has assisted in 
the recognition of certain proteins as regulatory components, such as cyclophilin D and ANT1. VDAC was also 
initially considered as a structural component, however, tissues engineered to lack all known isoforms still exhib-
ited mPT pore opening and regulation, reviewed in64. Furthermore, closure of VDAC hastened mPT pore open-
ing by means of impeding the efflux of superoxide anions from the intermembrane space65. Likewise, the outer 
membrane translocator protein of 18 kDa, TSPO, was originally reported to participate in mPT regulation66–68, a 
claim to be recently disproved69. Prior to the report that ANT-deficient mice still exhibit the mPT26, the ANT was 
already dismissed as a structural element of the pore in dimer formation induced by pore-inducing oxidants70; 
however, formation of ANT dimers need not materialize for pore assembly. Oxidants and other chemical modifi-
ers are known to modulate the mPT; there are at least three sites for oxidation tuning a sensor that translates the 
changes of both transmembrane voltage and surface potential into changes of the mPT pore open probability63. 
The critical arginines thought to tune the voltage sensor of the pore were considered not to reside in the ANT18,19. 
However, the experiments shown above support the notion that in human fibroblast mitochondria and in C2C12 
myotubes the sensor -or at least a part of it- is likely to be isoform 1 of the ANT. Therefore, the sensing property 
of ANT1 is not mediated through its arginines. The possibility that other oxidation-prone sites tuning the pore 
sensor reside on ANT1 remains high; indeed, in the presence of oxidants, ANT1−/− /ANT2−/− deficient mice 
exhibited more than three times higher maximum Ca2+ uptake capacity compared to wild-type mice26.
Figure 8. ANT2 expression and ADP/ATP exchange rates as a function of mitochondrial membrane 
potential. (A) Reverse transcription PCR and amplification of cDNAs reflecting expression of ANT2 gene in 
cultured fibroblasts of the patient (AF), the heterozygous mother (ST) and three control subjects, as a ratio to  
β-actin expression. (B) Plot of ATP–ADP exchange rate mediated by ANT versus ΔΨm in in situ mitochondria 
of AF (grey squares), ST (black squares) and control subjects (white symbols) permeabilized cells depolarized to 
various voltages by increasing amounts of SF 6847; constructed from the data of 3 independent experiments.
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Most of the experiments by Bernardi’s group that proved the inverse correlation of the proton electrochem-
ical gradient to mPT pore opening probability were performed with rat liver mitochondria where ANT2 is the 
dominant isoform mediating ADP/ATP exchanges, however, in rats ANT1 also exhibits significant expression71.
ANT1 (but not ANT2) is considered proapoptotic72. The proapoptotic property of ANT1 is extremely domi-
nant: overexpression of ANT1 in tumors in vivo (where otherwise ANT2 is mostly expressed) induces apoptosis 
and tumor regression73. However, silencing of ANT1 expression in a human glioblastoma cell line induced a 
paraptotic-like process74. On the other hand, overexpression of ANT1 is associated with autosomal dominant 
facioscapulohumeral muscular dystrophy75. In addition, it was shown that mice deficient in ANT1 exhibit 
increased resistance to excitotoxic insults of the brain76. Brain mitochondria from these mice exhibited ~20% 
higher maximum Ca2+ uptake capacity; unfortunately they were not investigated for mPT under de-energized 
conditions76.
In26, WT and ANT1−/−/ANT2−/− -deficient mouse liver mitochondria responded equally to 
uncoupler-induced swelling; we also found no statistically significant difference between ST, control and AF cells, 
even though there was a trend for AF mitochondria to exhibit smaller ‘onset to mPT’ values. As a word of caution 
though: the ANT1−/−/ANT2−/− -deficient mice mitochondria exhibited stark differences in bioenergetic param-
eters and expression levels of other mitochondrial proteins26, likely the result of compensatory mechanisms, while 
in this study fibroblasts and C2C12 myotubes were not confounded by other bioenergetic alterations, in line with 
the results obtained in34. However, it is interesting that in AF cells there seems to be a rebound upregulation in 
ANT2 expression. Since this was observed in Western blots but not Northern blots, it is likely to be due to reg-
ulation in the posttranslational modification of the ANT2 protein, and/or its degradation pathway. Relevant to 
this, different voltage-sensing properties of different ANT isoforms is a possibility. We do acknowledge though 
that to truly isolate ANT1’s functions from possible compensatory effects of other ANT isoforms, re-introduction 
of expression of ANT isoform 1 in AF cells would prove that only ANT1 is sensitive to alterations of the electro-
chemical gradient. However, to achieve this, ANT1 level expression should be matched to those observed in the 
control cell lines, a task posing serious technological challenges.
There is an important difference between de-energization of cells by glucose deprivation and either chemical 
anoxia, or an uncoupler; in the former, there is no electron flow in the electron transport chain; in the latter, 
there is high electron flow, despite glucose deprivation due to the presence of endogenous substrates that can fuel 
the citric acid cycle and yield reducing equivalents. mPT is indeed tuned by a voltage sensor, but in addition to 
that, electron flow through complex I strongly dictates pore-opening probability15,77,78 and is maybe part of the 
voltage-sensing mechanism. Furthermore, there is a potential additional confounding factor regarding the action 
of uncouplers: mitochondrial Ca2+ release by uncouplers is usually ascribed to matrix acidification79,80, which 
induces dissociation of the Ca2+phosphate complex. However, matrix acidification by nigericin in the presence 
of a complete collapse of ΔΨm by combined inhibition of the respiratory chain and the F0-F1 ATP synthase, lead 
to the release of only one-fifth of sequestered calcium61,81. Thus, uncouplers exert some other, yet to be identified, 
effect regarding matrix Ca2+ release, which may share a common denominator with induction of the permeability 
transition.
In the present report we show that in in situ mitochondria of ANT1-deficient human fibroblast and C2C12 
cells with knocked-down ANT1 by a lentiviral approach, the hastening of Ca2+-induced mPT pore opening 
during glucose deprivation and chemical anoxia is reduced or abolished. A similar picture emerged from or 
H2O2- treated cells shown to induce mPT opening, with well-documented adverse bioenergetic effects. Finally, 
voltage-thresholds of calcium-induced mPT opening in permeabilized C2C12 cells were higher if ANT1 was 
knocked down, than scramble RNA treated cells. We therefore conclude that ANT1 is the module conferring sen-
sitivity of the pore to voltage likely through the electrochemical proton gradient across the inner membrane and/
or the electron flow though the electron transport chain. This is in line with previous postulations that ANT either 
exerts an indirect effect on the mPT by influencing surface potential82,83, or through altered ANT conformation 
induced by adenine nucleotide binding affected by membrane potential32.
Materials and Methods
Cell cultures and transfections. Fibroblast cultures from skin biopsies from the patient with no ANT1 
expression (AF) the heterozygous mother (ST) and three control subjects were prepared. All experiments were 
conducted in accordance with the guidelines of Ethical Rules for Using Human Tissues for Medical Research in 
Hungary (HM 34/1999) and the Code of Ethics of the World Medical Association (Declaration of Helsinki), and 
were approved by the Strasbourg University Hospital Ethics Committee. Informed consent was obtained from 
the patient, her mother, and three healthy donors. Cells were grown on poly-L-ornithine coated 8-well LabTek II 
chambered coverglasses (Nunc, Rochester, NY, USA) for 2–3 days, at a density of approximately 3*105 cells/well 
in RPMI1640 medium (GIBCO, Life technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine 
serum and 2 mM glutamine and kept at 37 °C in 5% CO2. The medium was also supplemented with penicillin, 
streptomycin and amphotericin (item A5955, Sigma-Aldrich St. Louis, MO, USA). Cultures were transfected on 
the 1st or 2nd DIV with mito-DsRed2 using Lipofectamine 2000 (Life technologies) in RPMI1640 medium at a 
3:2 ratio of Lipofectamine (μl) to plasmid DNA (μg) or with mitochondria targeted FRET-based calcium indica-
tor, 4mtD3cpv using flashFECTIN (Oxford Expression Technologies, Oxford, UK) according to the manufactur-
er’s instructions. Experiments were carried out at day 1–2 post transfection. Typical transfection rates were <5% 
and therefore individual, non-overlapping cells were visualized.
Imaging of cultured cells and estimation of in situ mitochondrial swelling with the TR tech-
nique. Time lapse epifluorescence microscopy was carried out to image cells expressing mito-DsRed2 at 34 °C 
and swelling of in situ mitochondria was measured by the thinness ratio (TR) technique exactly as described in44. 
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Basically, cells were imaged directly on the LabTek chamber without superfusion in a medium contain-
ing (in mM): 120 NaCl, 3.5 KCl, 1.3 CaCl2, 20 HEPES, 15 glucose (where indicated) at pH 7.4. Experiments 
were performed on an Olympus IX81 inverted microscope equipped with a 60 × 1.4 NA oil immersion lens, a 
Bioprecision-2 xy-stage (Ludl Electronic Products Ltd., Hawthorne, NY) and a 75W xenon arc lamp (Lambda 
LS, Sutter Instruments, Novato, CA). For mito-DsRed2 an 535/20 nm exciter, a 555LP dichroic mirror and an 
570LP emitter (Omega Optical, Brattleboro, VT) were used. Time lapses of z-series of 16 planes of 512 × 512 
pixels frames (digitized at 14bit with no binning, 250 ms exposure time, yielding 0.1 μm pixel size and 0.8 μm 
z-spacing) were acquired using an ORCA-ER2 cooled digital CCD camera (Hamamatsu Photonics, Hamamatsu, 
Japan) under control of MetaMorph 6.0 software (Molecular Devices; Sunnyvale, CA, USA). The TR technique 
measures changes of average diameters of thread-like or punctate structures in fluorescence images using a pair 
of (high and low frequency) bandpass spatial filters. A calibration image series of mito-DsRed2 fluorescence 
showing mitochondrial swelling by valinomycin (200 nM) was recorded and used to train a spatial bandpass filter 
set in Image Analyst MKII (Image Analyst Software, Novato, CA). To calculate TR, for each time point the z-stack 
was mean-intensity projected and the projection image was duplicated. Then, both images were spatially filtered 
and the absolute value of pixels was taken. The TR was calculated as the ratio of the average fluorescence intensity 
in the high frequency band pass filtered over the low frequency band pass filtered image. Mitochondrial swelling 
causes the loss of high spatial frequency image details, therefore a decrease in the TR value. Baseline normalized 
TR is given as δTR = (TR − TR0)/TR0.
Mitochondrial Ca2+ imaging. Two imaging approaches were used: X-Rhod-1 imaging or mitochondria 
targeted FRET-based calcium indicator, 4mtD3cpv imaging. In X-Rhod-1 experiments cultured cells were 
loaded with 4 micromole X-Rhod-1-AM for 15 min at 37 °C, in a medium containing (in mM): 120 NaCl, 3.5 
KCl, 1.3 CaCl2, 20 HEPES, 15 glucose (where indicated) at pH 7.4, then for 25 min cultures were kept in dark 
for ‘de-esterification’. Experiments were performed at 34 °C on the setup mentioned above with a 60 × 1.4 NA oil 
immersion lens. For XRhod1 a 535/20 nm exciter, a 555LP dichroic mirror and a 570 LP emitter were used, all 
from Chroma Technology Corp., Bellows Falls, VT, USA. Time lapses of z-series of 5 planes of 1342 × 1024 pixels 
frames (digitized at 14bit with no binning, 250 ms exposure time, yielding 0.1 μm pixel size and 1.6 μm z-spacing) 
were acquired. For each time point the z-stack was mean-intensity projected. In 4mtD3cpv experiments cul-
tured cells were imaged in a medium containing (in mM): 120 NaCl, 3.5 KCl, 1.3 CaCl2, 20 HEPES, 15 glu-
cose (where indicated) at pH 7.4. Experiments were performed at 34 °C on the setup mentioned above with 
a 60 × 1.4 NA oil immersion lens. For 4mtD3cpV the following filter sets were used: a 440/20 exciter, a dual 
bandpass (450–490 nm and 520–560 nm transmitting) dichroic mirror, a 480/10 emitter for CFP (CFP channel) 
and 535/20 emitter for YFP variant (FRET channel), all from Chroma Technology Corp., Bellows Falls, VT. Time 
lapses of 1344 × 1024 pixels frames for both channels (digitized at 14 bit with no binning, 400 msec exposure 
times) were acquired.
Estimation of onset of mPT with the cobalt-calcein technique. Because transfection efficiency with 
mito-DsRed2 was low, in addition to the thinness ratio technique we assessed onset of mPT implying in situ mito-
chondrial swelling by the cobalt-calcein method, developed by Petronilli et al.43. Briefly, cells were loaded with 
50 nM calcein-AM (above 100 nM, calcein was toxic for these cells) for 20 min at 4 °C, in a medium containing 
(in mM): 120 NaCl, 3.5 KCl, 1.3 CaCl2, 20 HEPES, 15 glucose (where indicated) at pH 7.4. Subsequently, 1 mM 
CoCl2 was added, and the LabTek chamber was mounted on the microscope stage. Experiments were performed 
at 34 °C on the setup mentioned above with a 60 × 1.4 NA oil immersion lens. For calcein an 488/6 nm exciter, 
a 505LP dichroic mirror and an 535/25 emitter (all from Chroma Technology Corp., Bellows Falls, VT) were 
used. Time lapses of z-series of 5 planes of 1342 × 1024 pixels frames (digitized at 14 bit with no binning, 250 ms 
exposure time, yielding 0.1 μm pixel size and 1.6 μm z-spacing) were acquired. For each time point the z-stack 
was mean-intensity projected.
Simultaneous measurement of mitochondrial (ΔΨm) and plasma membrane potential 
(PMP). Cultures were incubated at 37°C in imaging medium containing (in mM): 120 NaCl, 3.5 KCl, 
1.3 CaCl2, 20 HEPES, 15 glucose (where indicated) at pH 7.4 with TMRM (180 nM) plus the bis-oxonol type 
plasma membrane potential indicator, DIBAC4(3) (250 nM, Life Technologies Inc.) for 60 min before the exper-
iment. Experiments were performed at 34 °C on the setup mentioned above with a UAPO 20× air 0.75NA lens. 
Time lapses of 1342 × 1024 pixels frames (digitized at 12 bit with 4 × 4 binning, 250 msec exposure time for TMRM 
and 100 msec exposure time for DIBAC4(3) were acquired. For the illumination of DIBAC4(3) a 490/10 nm exciter, 
a 505LP dichroic mirror and 535/25 emission filter were used, for TMRM a 535/20 nm exciter, a 555LP dichroic 
mirror and a 630/75 emitter were used, all from Chroma Technology Corp., Bellows Falls, VT. The cross-talk 
of TMRM and DIBAC4(3) emissions was eliminated by a linear spectral un-mixing algorithm implemented in 
Image Analyst MKII (Image Analyst Software, Novato, CA) as previously described51, using decomposition algo-
rithms developed in52. The algorithm calculates un-mixed fluorescence intensities by solving a linear equation 
with the cross-talk coefficient matrix. Coefficient matrix was determined by loading the cultures either with 
TMRM or DIBAC4(3) while both emissions (TMRM and DIBAC4(3)) were recorded, see Supplementary Fig. 1. 
At the end of every experiment, full mitochondrial depolarization and plasma membrane depolarization was 
achieved by the application of mitochondrial (MDC) and plasma membrane depolarization cocktails (CDC). 
MDC contained (in μM): 1 valinomycin, 1 SF 6847, 2 oligomycin; CDC contained (in μM): 1 valinomycin, 1 SF 
6847, 2 oligomycin, 10 nigericin, 10 monensin.
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Northern blotting. Total RNA was isolated using Trizol reagent (Life technologies). RT-PCR was performed 
with the Phusion RT-PCR kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. 
Primers (Sigma-Aldrich, St. Louis, MO, USA) were designed using Primer 384, and were identical to those used 
by Le Bras et al.85. The primers were the following: hANT1-F: ATGGGTGATCACGCTTGGAGCTTCCTAAAG 
and hANT1-R: TTAGACATATTTTTTGATCTCATCATACAA, hANT2-F: cagcagtctgcctcctcttt and hANT2-R: 
aagctttgcctccttcatca.
qPCR. Total RNA from the fibroblast cultures was isolated using Trizol reagent (Life technologies). cDNA 
was synthesized with Oligo d(T)23 VN primer (New England Biolabs, Ipswich, MA, USA) and M-MuLV 
Reverse Transcriptase (New England Biolabs) as recommended by the manufacturer. Real-time PCR was 
performed using Power SYBR PCR Mastermix (Life Technologies) and ABI 7900HT Fast Real Time PCR 
cycler. Primer sequences were obtained from PrimerBank (http://pga.mgh.harvard.edu/primerbank/
index.html): ATCACGCTTGGAGCTTCCTAA - ANT1-F, TGCTTCTCAGCACTGATCTGT – ANT1-R; 
TTATAGACTGCGTGGTCCGTA – ANT2-F; GGCGAAGTTAAGAGCCTGGG – ANT2-R. The results were 
normalized with the housekeeping human β-actin gene (primers: CTGGCACCCAGCACAATG– HsACTB-F; 
CCGATCCACACGGAGTACTTG– HsACTB-R86). The data were obtained from 3 independent experiments.
Ant1-silenced C2C12 stable cells. Mouse Ant1 in C2C12 cells was silenced with MISSION shRNA len-
tiviral transduction particles (Sigma, St Louis, MO), as described previously56. Briefly, stable cells were created 
based on the manufacturer’s protocol in C2C12 myoblasts and selected with 1 mg/ml puromycin. Scrambled 
shRNA lentivirus was used to create the control cell line.
Harvesting and permeabilization of cells for ADP-ATP exchange rate measurements and 
determination of membrane potential. Approximately 1 million fibroblasts (per experiment) cul-
tured as above in poly-L-ornithine coated T-175 cm2 flasks (Nunc, Rochester, NY, USA) were washed once in 
phosphate-buffered saline and harvested with 1 ml of 0.25% trypsin-EDTA, inactivated by 9 ml calf serum, fol-
lowed by centrifugation at 1,100 g for 2 minutes. Next, cells were washed once in ice-cold buffer containing, in 
mM: KCl 8, K-gluconate 110, NaCl 10, Hepes 10, KH2PO4 10, EGTA 0.005, mannitol 10, MgCl2 1, and 0.5 mg/ml 
bovine serum albumin (fatty acid-free), pH 7.25 without disturbing the pellet. After the wash, cells were resus-
pended in 0.2 ml of the same buffer but pre-warmed to 37 °C and also including mitochondrial substrates (5 mM 
glutamate and 5 mM malate), 25 μM sodium orthovanadate, beryllium trifluoride (see below regarding final con-
centration) and 50 μM digitonin. Both ADP-ATP exchange rate- and ΔΨm measurements of in situ mitochondria 
in permeabilized cells occurred in this buffer. The rationale for using this particular buffer composition is elabo-
rated in87,88. Glutamate and malate were chosen as mitochondrial substrates because they support mitochondrial 
substrate-level phosphorylation, and as such, they contribute to greater ATP efflux rates46,49,50.
[Mg2+]free determination from Magnesium Green fluorescence in the experimental volume 
containing permeabilized fibroblasts and conversion to ADP-ATP exchange rate. ADP-ATP 
exchange rate was estimated using the recently described fluorimetric method by our laboratory87, exploiting the 
differential affinity of ADP and ATP to Mg2+, with the modifications required for digitonin-permeabilized cells, 
using sodium orthovanadate and beryllium trifluoride, see below and ref. 88. The rate of ATP appearing in the 
medium following addition of ADP (2 mM) to energized in situ mitochondria was calculated from the measured 
rate of change in free extramitochondrial [Mg2+] using standard binding equations. [Mg2+] in the extramito-
chondrial environment was measured using the fluorescent indicator, Magnesium Green 5K+ salt (1 μM). The 
assay is designed such that the ANT is the sole mediator of changes in [Mg2+]free in the extramitochondrial vol-
ume, as a result of ADP-ATP exchange. For the calculation of [ATP] or [ADP] from [Mg2+]free, the apparent Kd 
values are identical to those in (26) due to identical experimental conditions (KADP = 0.906 ± 0.023 mM, and 
KATP = 0.114 ± 0.005 mM). Magnesium Green fluorescence was recorded in Tecan Infinite® 200 PRO series plate 
reader (Tecan Deutschland GmbH, Crailsheim, Germany) at a 0.5 Hz acquisition rate, using 505 and 535 nm 
excitation and emission wavelengths, respectively. Experiments were performed at 37 °C.
Mitochondrial membrane potential (ΔΨm) determination of in situ mitochondria of perme-
abilized cells. ΔΨm was estimated using fluorescence quenching of the cationic dye safranin O due to its 
accumulation inside energized mitochondria46, also taking into account the considerations discussed in89 and90. 
Briefly, ~30,000 C2C12 cells (per experiment) were cultured in 35 mm wells or ~1 million fibroblasts (per exper-
iment) cultured in poly-L-ornithine coated T-175 cm2 flasks were washed once in phosphate-buffered saline and 
harvested with 0.25% trypsin-EDTA, inactivated by calf serum, followed by centrifugation at 1,100 g for 2 min-
utes. Next, cells were washed once in an ice-cold buffer containing, in mM: KCl 8, K-gluconate 110, NaCl 10, 
Hepes 10, KH2PO4 10, EGTA 0.005, mannitol 10, MgCl2 1, and 0.5 mg/ml bovine serum albumin (fatty acid-free), 
pH 7.25 without disturbing the pellet. After the wash, cells were resuspended in 0.2 ml of the same buffer but 
pre-warmed to 37 °C and also including mitochondrial substrates (5 mM glutamate and 5 mM malate), 5 μM 
safranin O and 50 μM digitonin. For results obtained from fibroblasts, traces obtained from safranin O fluores-
cence were calibrated to millivolts as described in ref. 50. For results obtained from C2C12 cells, traces are shown 
as arbitrary units of safranine O fluorescence. Fluorescence was recorded in a Tecan Infinite® 200 PRO series 
plate reader at a 0.08 Hz acquisition rate, using 495 and 585 nm excitation and emission wavelengths, respec-
tively. After the completion of each experiment, cells were harvested from each well and protein content was 
determined. Only those data were considered in which protein content variability among wells was <5%. All 
experiments were performed at 37 °C and in triplicates.
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Mitochondrial calcium uptake capacity in permeabilized C2C12 cells. Maximum Ca2+ uptake 
capacity of in situ mitochondria of permeabilized cells was estimated as detailed previously57, with minor modifi-
cations: Briefly, approximately 30,000 C2C12 cells (per experiment) were cultured in 35 mm wells, washed once in 
phosphate-buffered saline and harvested with 0.2 ml of 0.25% trypsin-EDTA, inactivated by 1.8 ml calf serum, fol-
lowed by centrifugation at 1,100 g for 2 minutes. Next, cells were washed once in an ice-cold buffer containing, in 
mM: KCl 8, K-gluconate 110, NaCl 10, Hepes 10, KH2PO4 10, EGTA 0.005, mannitol 10, MgCl2 1, and 0.5 mg/ml 
bovine serum albumin (fatty acid-free), pH 7.25 without disturbing the pellet. After the wash, cells were resus-
pended in 0.2 ml of the same buffer, but pre-warmed to 37 °C and also including mitochondrial substrates (5 mM 
glutamate and 5 mM malate), 1 μM Calcium Green 5N hexapotassium salt, (CaGr, Life Technologies) and 50 μM 
digitonin. Consecutive additions of CaCl2 was added (100 μM boluses) or NaCN (50 μM boluses) or SF6847 (10 
or 100 nM boluses) where indicated, until there was no further decrease in CaGr fluorescence, or upon reaching 
maximum depolarization inferred by parallel measurements of mitochondrial membrane potential measured by 
safranine O as detailed above. Fluorescence was recorded in a Tecan Infinite® 200 PRO series plate reader at a 
0.08 Hz acquisition rate, using 506 and 531 nm excitation and emission wavelengths, respectively. All experiments 
were performed at 37 °C and in triplicates. After the completion of each experiment, cells were harvested from 
each well and protein content was determined. Only those data were considered in which protein content varia-
bility among wells was <5%.
Western blot analysis. C2C12 cells or human fibroblasts were harvested by trypsinization, washed in 
phosphate-buffered saline, solubilised in RIPA buffer containing a cocktail of protease inhibitors (Protease 
Inhibitor Cocktail Set I, Merck Millipore, Billerica, MA, USA) and frozen at −80 °C for further analy-
sis. Frozen pellets were thawed on ice, their protein concentration was determined using the bicinchoninic 
acid assay as detailed below and separated by sodium dodecyl sulfate – polyacrylamide gel electrophoresis 
(SDS-PAGE). Separated proteins were transferred to a methanol-activated polyvinylidene difluoride mem-
brane. Immunoblotting was performed as recommended by the manufacturers of the antibodies. Rabbit pol-
yclonal anti-ANT1 (Abcam, Cambridge, UK 1:500 dilution), rabbit polyclonal anti-ANT2 (Biogenesis, UK, 
1:500 dilution), rabbit monoclonal anti-VDAC1 (Abcam, 1:5,000 dilution) and mouse monoclonal anti-β actin 
(Abcam, 1:5,000 dilution) primary antibodies were used. Immunoreactivity was detected using the appro-
priate peroxidase-linked secondary antibody (1:5,000, donkey anti-rabbit or donkey anti-mouse, Jackson 
Immunochemicals Europe Ltd, Cambridgeshire, UK) and enhanced chemiluminescence detection reagent (ECL 
system; Amersham Biosciences GE Healthcare Europe GmbH, Vienna, Austria).
Cytochrome c release. Permeabilized C2C12 cells undergoing calcium uptake capacity determination 
using CaGr as detailed above were collected at specified time points, and centrifuged at 21,000 g for 3 min. The 
supernatants were carefully removed, and both the supernatant and pellet fractions were immediately frozen 
and stored at −20 °C. Cytochrome c immunoreactivity was quantified in both fractions using an enzyme-linked 
immunosorbent assay kit (Abcam). Before measurement, the supernatant and pellet samples were diluted 1:20 
and 1:200, respectively. The release of cytochrome c from in situ mitochondria is expressed as the content of 
cytochrome c in the supernatant as a percentage of the total content of cytochrome c present in the supernatant 
plus pellet.
Preparation of sodium orthovanadate (Na3VO4) and beryllium trifluoride (BeF3−). A 25 mM 
Na3VO4 solution was prepared in distilled water (>17 mOhm resistance). The pH of the solution was adjusted 
to 8.7 with HCl, upon which it turns yellow. This solution was boiled until it turns colorless and cooled to room 
temperature. The pH was reassessed, and readjusted to pH 8.7 with HCl, upon which the solution turned yellow 
again. This cycle of boiling until colorless and readjusting the pH was repeated until the solution remains colorless 
at pH 8.7. Finally, the solution was brought up to the initial volume with distilled water and stored in aliquots at 
−80 °C. This treatment removes all decavanadate ions present in the Na3VO4 solution, which induces mitochon-
drial membrane depolarization and inhibition of oxygen consumption91. The final concentration of orthova-
nadate used was 12.5 μM. Orthovanadate inhibits the oxidation of only disrupted mammalian mitochondria92. 
Likewise, fluoroberyllium nucleoside diphosphate complexes inhibit only the exposed F1F0-ATPase93. BeSO4 
and NaF are prepared as aqueous solutions of 0.2 M and 0.5 M, respectively, and kept at +4 °C for several years. 
0.2 mM BeF3− is formed immediately in solution upon mixing of BeSO4 (0.2 mM) and NaF (5 mM). Vanadate, 
beryllium and fluoride salts are highly toxic to tissues and to the environment, and thus require proper han-
dling and disposal. The combination of orthovanadate and BeF3− inhibits kinases, mutases, phosphatases, and 
ATPases94,95. However, some kinases, such as pyruvate kinase, will remain uninhibited96. In this respect, upon 
permeabilization of the cells one has to totally separate pyruvate kinase from its substrate, phosphoenol pyruvate, 
i.e. there must be no glucose present in the medium prior to permeabilization, and a few minutes lag time must 
be allowed prior to ADP-ATP exchange rate measurements in order for the remaining reactions by kinases to 
‘die-out’.
Protein determination. Protein content was measured by the bicinchoninic acid assay97 using bovine 
serum albumin protein as standards and calibrating by a 3 parameter power function, f = y0 + a*xb, where y0 
is background absorbance in the absence of protein, a and b are constants, and x is the amount of protein in the 
unknown samples.
Reagents. Standard laboratory chemicals, safranine O and digitonin were from Sigma. Calcium Green 5N 
6K+ salt, Magnesium Green 5K+ salt and calcein-AM were from Life technologies. SF 6847 was from Biomol 
(BIOMOL GmbH, Hamburg, Germany). Fetal bovine serum was from Atlanta Biologicals (Lawrenceville, GA, 
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USA) and all other tissue culture reagents were purchased from Life technologies. pDsRed2-mito (mito-DsRed2) 
was purchased from Clontech (Mountain View, CA). pcDNA-4mtD3cpv was a gift from Amy Palmer & Roger 
Tsien (Addgene plasmid # 36324).
Statistics. Data are presented as mean ± SEM; significant differences between two groups of data were evalu-
ated by Student’s t-test, with p < 0.05 considered significant. Significant differences between three or more groups 
of data were evaluated by one-way analysis of variance followed by Tukey’s post-hoc analysis, with p < 0.05 con-
sidered statistically significant. If normality test failed, ANOVA on Ranks was performed.
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